✦ LIBER ✦

Construction of fusion proteins consisting of ADH and FDH for NADH regeneration

✍ Scribed by Xi Wu; Chong Zhang; Xinhui Xing

Book ID: 113683047
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 56 KB
Volume: 108
Category: Article
ISSN: 1389-1723
DOI: 10.1016/j.jbiosc.2009.08.309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Construction of bifunctional fusion prot

Construction of bifunctional fusion proteins consisting of duck BAFF and EGFP

✍ Wen-Bing Dan; Chao Zhang; Zheng-Bing Guan; Shuang-Quan Zhang 📂 Article 📅 2007 🏛 Springer Netherlands 🌐 English ⚖ 293 KB

The construction of bifunctional fusion

The construction of bifunctional fusion proteins consisting of MutS and GFP

✍ Anna Stanisławska-Sachadyn; Paweł Sachadyn; Karolina Ihle; Cezary Sydorczuk; Kat 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 734 KB

Design and optimization of a linker for

Design and optimization of a linker for fusion protein construction

✍ Jianhua Zhang; Jun Yun; Zhigang Shang; Xiaohui Zhang; Borong Pan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Construction, Expression and Refolding o

Construction, Expression and Refolding of a Bifunctional Fusion Protein Consisting of C-Terminal 12-Residue of Hirudin-PA and Reteplase

✍ Ling Gao, Chun Zhang, Lingling Li, Lan Liang, Xuan Deng, Wutong Wu, Zhiguo Su, R 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 317 KB

Construction of a dual-tag system for ge

Construction of a dual-tag system for gene expression, protein affinity purification and fusion protein processing

✍ Hassan Motejadded; Josef Altenbuchner 📂 Article 📅 2009 🏛 Springer Netherlands 🌐 English ⚖ 461 KB

Construction and evaluation of novel fus

Construction and evaluation of novel fusion proteins for targeted delivery of micro particles to cellulose surfaces

✍ William Lewis; Eli Keshavarz-Moore; John Windust; Donna Bushell; Neil Parry 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 2 views

## Abstract The use of IgG antibodies and fragments has been limited to specific sectors of the biotechnology industry due to the high cost of producing large batches of product necessary for alternative applications. A novel class of Camelid antibodies, known as V~HH~ offer a more economical oppor